ABBVIE wants GERN. ABBVIE is already using GERN'S drug in AML. ABBVIE paid $262 a share to steal PCYC, GERN'S sister company away from Johnson and Johnson only GERN'S technology is 1,000 times better then PCYC's and GERN'S technology won the Nobel Prize